Establishing the Diagnostic and Prognostic Value of Serum Interleukin 6 Levels in Sepsis

1. Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.10.1056/NEJMoa02213912700374Search in Google Scholar

2. Deutschman CS, Tracey KJ. „Sepsis: current dogma and new perspectives”. Immunity 2014; 40 (4): 463–75.10.1016/j.immuni.2014.04.00124745331Search in Google Scholar

3. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med. 2011; 12(2): 165–73.10.1097/PCC.0b013e3181e28876292446220473243Search in Google Scholar

4. Feng M, Sun T, Zhao Y, Zhang H. Detection of serum interleukin-6/10/18 levels in sepsis and its clinical significance. J Clin Lab Anal. 2016; DOI:10.1002/jcla.21977.10.1002/jcla.21977680722327184083Search in Google Scholar

5. Petilla V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 2002; 28(9):1220–5.10.1007/s00134-002-1416-112209268Search in Google Scholar

6. Khan A, Ali Z. Normal Ranges for Acute Phase Reactants (Interleukin-6, Tumour Necrosis Factor-alpha and C-reactive Protein) in Umbilical Cord Blood of Healthy Term Neonates at the Mount Hope Women’s Hospital, Trinidad. West Indian Med J. 2014; 63 (5):465-9.Search in Google Scholar

7. Georgescu AM, Banescu C, Badea I, et al. IL-6 gene polymorphisms and sepsis in ICU adult romanian patients: a prospective study. Rev Romana Med Lab. 2017;25(1):75–89.10.1515/rrlm-2016-0044Search in Google Scholar

8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JV, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4):1250-6.10.1097/01.CCM.0000050454.01978.3B12682500Search in Google Scholar

9. Dellinger RH, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013. Feb;41(2):580-637.10.1097/CCM.0b013e31827e83af23353941Search in Google Scholar

10. Pallás Beneyto LA, Rodríguez Luis O, Saiz Sánchez C, Coltell O, Bautista Rentero DB, Bayarri VM. Prognostic Value of Interleukin 6 for Death of Patients With Sepsis. Med Clin. 2016; 147(7):281-6.10.1016/j.medcli.2016.06.00127422737Search in Google Scholar

11. Miguel-Bayarri V, Casanoves-Laparra EB, Pallás-Beneyto L, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Int. 2012; 36(8):556–62.10.1016/j.medine.2012.10.008Search in Google Scholar

12. Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005; 33(4):792-6.10.1097/01.CCM.0000159089.16462.4ASearch in Google Scholar

13. Khosravani H, Shahpori R, Stelfox HT, Kirkpatrick AW, Laupland KB. Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Crit Care. 2009; 13(3):R90.10.1186/cc7918Search in Google Scholar

14. Abe T, Suzuki T, Kushimoto S, et al. History of diabetes may delay antibiotic administration in patients with severe sepsis presenting to emergency departments. Medicine (Baltimore). 2020; 99(11):e19446.10.1097/MD.0000000000019446Search in Google Scholar

15. Chen CH, Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE). The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study. J Clin Med. 2018;7 (11):393.10.3390/jcm7110393Search in Google Scholar

16. Onal EE, Kitapçi F, Dilmen U, Adam B. Interleukin-6 concentrations in neonatal sepsis. Lancet. 1999; 16(353):239–40.10.1016/S0140-6736(05)77250-0Search in Google Scholar

17. Park DW, Chun BC, Kim JM, et al. Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea. J Korean Med Sci. 2012;27(11):1308-14.10.3346/jkms.2012.27.11.1308349266323166410Search in Google Scholar

18. Barre M, Behnes M, Hamed S, et al. Revisiting the Prognostic Value of Monocyte Chemotactic Protein 1 and interleukin-6 in the sepsis-3 Era. J Crit Care. 2018; 43:21-28.10.1016/j.jcrc.2017.08.02428834779Search in Google Scholar

19. Naffaa M, Makhoul BF, Tobia A, Kaplan M, Aronson D, Saliba W, Azzam ZS. Interleukin-6 at Discharge Predicts All-Cause Mortality in Patients With Sepsis. Am J Emerg Med 2013; 31(9): 1361-4.10.1016/j.ajem.2013.06.01123896015Search in Google Scholar